- LCTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Lineage Cell Therapeutics (LCTX) 10-K/A2019 FY Annual report (amended)
Filed: 28 Apr 20, 5:00pm
Exhibit 31.4
CERTIFICATIONS
I, Brandi Roberts, certify that:
1. | I have reviewed this Amendment No. 1 on Form 10-K/A to the Annual Report on Form 10-K of Lineage Cell Therapeutics, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
Date: April 28, 2020
/s/ Brandi Roberts | |
Brandi Roberts | |
Chief Financial Officer |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.